23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.
The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
regarding whether the board of directors and the co-founder and current CEO Anne Wojcicki ("Wojcicki") of 23andMe breached their fiduciary duties in connection with Wojcicki's ongoing effort ...
Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its board resigned en masse Tuesday. The move is almost certainly the final ...
Good morning, Broadsheet readers! All board members resigned from Anne Wojcicki’s 23andMe, Teresa Ribera will likely become Europe’s new antitrust chief, and Midi Health raises $5 million from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback